Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International consensuses and guidelines on managing ocular Behçet's disease by the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO), the Asia-Pacific Vitreo-Retina Society (APVRS), the Asia-Pacific Society of Ocular Inflammation and Infection (APSOII) and the Academia Retina Internationalis (ARI).

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2025
Same author

A pilot study : retinal sensitivity change in neovascular age-related macular degeneration patients with better baseline visual acuity.

Scientific reports·2024
Same author

Selective retina therapy with real-time feedback-controlled technology in central serous chorioretinopathy: a 24-month follow-up real-world prospective study.

BMJ open ophthalmology·2024
Same author

Vitrectomy for Retinoschisis in Papillorenal Syndrome Related to PAX2 Mutation.

Ophthalmology·2023
Same author

Volumetric fluid analysis of fixed monthly anti-VEGF treatment in patients with neovascular age-related macular degeneration.

International journal of ophthalmology·2023
Same author

Retinal vessel geometry in patients with idiopathic epiretinal membrane.

Scientific reports·2023

Related Experiment Video

Updated: Jun 16, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Secondary macular hole formation after vitrectomy.

Sun Ho Lee1, Kyu Hyung Park, Jeong Hun Kim

  • 1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Republic of Korea.

Retina (Philadelphia, Pa.)
|February 20, 2010
PubMed
Summary

Secondary macular holes (MHs) after vitrectomy are rare, occurring in 0.24% of cases. Surgical repair offers good outcomes, but final visual acuity depends on the initial eye condition.

More Related Videos

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Related Experiment Videos

Last Updated: Jun 16, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
11:20

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery
04:36

Implantation Protocol of the Foldable Capsular Vitreous Body for Complex Vitreoretinal Surgery

Published on: April 14, 2026

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

Area of Science:

  • Ophthalmology
  • Retinal Surgery
  • Macular Diseases

Background:

  • Vitrectomy is a common surgical procedure for various retinal conditions.
  • Secondary macular holes (MHs) can occur after vitrectomy, necessitating further investigation.

Purpose of the Study:

  • To determine the incidence of secondary MHs in vitrectomized eyes.
  • To identify the underlying ocular pathologies associated with these secondary MHs.
  • To evaluate the prognosis and outcomes of secondary MHs.

Main Methods:

  • Retrospective chart review of patients who underwent vitrectomy.
  • Identification and data collection for cases developing secondary MHs.
  • Exclusion of patients with recurrent MHs post-initial surgery.

Main Results:

  • An incidence of 0.24% (8 of 3,279 eyes) for secondary MHs was observed.
  • Underlying pathologies included proliferative diabetic retinopathy, high myopia with retinal detachment, uveitis, and epiretinal membranes.
  • Surgical management (vitrectomy, ILM peeling, gas tamponade) resulted in a 90% hole closure rate and visual acuity recovery in 80% of eyes.

Conclusions:

  • Secondary MHs following vitrectomy are uncommon, suggesting distinct pathogenic mechanisms.
  • Surgical outcomes for secondary MHs are generally favorable.
  • Final visual acuity is influenced by the pre-existing ocular pathology.